Skip to main content

Table 1 Characteristics of the subjects at baseline examination

From: The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery

VariableAll subjects N = 80
Age, years, mean (SD)40.8 (12.7)
Sex, male, n (%)24 (30.0%)
Weight, kg, mean (SD)128.7 (18.3)
Body-mass index, kg/m2, mean (SD)44.2 (3.9)
Waist circumference, cm, mean (SD)134.1 (10.1)
Cardiovascular risk factors, n (%)
 Preexisting cardiovascular disease1 (1.3%)
 Hypertension37 (46.3%)
 Type 2 diabetes mellitus25 (31.3%)
 Prediabetes (IGT or IFG)14 (17.5%)
 Current cigarette use33 (41.3%)
 Hyperlipidemia20 (25.0%)
Current therapy, n (%)
 Statins18 (22.5%)
 Oral glucose lowering agents18 (22.5%)
 Insulin5 (6.3%)
 Blood pressure lowering agents37 (46.3%)
 Angiotensin converting enzyme-inhibitors32 (40.0%)
 Beta-blockers19 (23.8%)
  1. IGT impaired glucose tolerance, IFG impaired fasting glucose